KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EBT: 2009-2025

Historic EBT for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $1.8 billion.

  • Thermo Fisher Scientific's EBT rose 4.82% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 billion, marking a year-over-year increase of 3.80%. This contributed to the annual value of $7.0 billion for FY2024, which is 11.73% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported EBT of $1.8 billion as of Q3 2025, which was up 6.85% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's EBT ranged from a high of $2.8 billion in Q2 2021 and a low of $1.4 billion during Q2 2023.
  • Over the past 3 years, Thermo Fisher Scientific's median EBT value was $1.7 billion (recorded in 2023), while the average stood at $1.7 billion.
  • In the last 5 years, Thermo Fisher Scientific's EBT surged by 232.49% in 2021 and then tumbled by 46.34% in 2023.
  • Thermo Fisher Scientific's EBT (Quarterly) stood at $1.9 billion in 2021, then decreased by 4.56% to $1.8 billion in 2022, then dropped by 2.08% to $1.7 billion in 2023, then rose by 11.55% to $1.9 billion in 2024, then grew by 4.82% to $1.8 billion in 2025.
  • Its EBT was $1.8 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.6 billion in Q1 2025.